|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Breztri_Aerosphere
gptkb:Trixeo_Aerosphere
gptkb:Symbicort
|
|
gptkbp:activities
|
glucocorticoid receptor agonist
|
|
gptkbp:approves
|
gptkb:legislation
gptkb:Australia
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:brand
|
gptkb:Entocort
gptkb:Pulmicort
gptkb:Rhinocort
|
|
gptkbp:category
|
Category B
|
|
gptkbp:clinical_trial
|
Phase III
maintenance therapy
acute exacerbations
long-term control
prevention of symptoms
|
|
gptkbp:contraindication
|
systemic fungal infections
hypersensitivity to budesonide
|
|
gptkbp:developed_by
|
gptkb:temple
|
|
gptkbp:discovered_by
|
gptkb:1980s
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:formulation
|
gptkb:beer
gptkb:tablet
gptkb:fragrance
gptkb:superhero
suspension
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
budesonide
|
|
gptkbp:ingredients
|
C25 H34 O6
|
|
gptkbp:interacts_with
|
CY P3 A4 inducers
CY P3 A4 inhibitors
|
|
gptkbp:is_atype_of
|
R03 B A02
|
|
gptkbp:is_available_on
|
generic drug
|
|
gptkbp:is_used_for
|
gptkb:asthma
gptkb:healthcare_organization
allergic rhinitis
|
|
gptkbp:lifespan
|
2 to 3 hours
|
|
gptkbp:manager
|
gptkb:fragrance
oral
inhalation
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:side_effect
|
headache
nausea
cough
throat irritation
|
|
gptkbp:storage
|
room temperature
dry place
protected from light
|
|
gptkbp:type_of
|
51333-22-3
|